XFOR
X4 Pharmaceuticals Inc
NASDAQ: XFOR · HEALTHCARE · BIOTECHNOLOGY
$4.10
-0.49% today
Updated 2026-04-29
Market cap
$374.59M
P/E ratio
—
P/S ratio
10.67x
EPS (TTM)
$-1.87
Dividend yield
—
52W range
$1 – $5
Volume
0.5M
X4 Pharmaceuticals Inc (XFOR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-65.6%
Last 4 quarters
Revenue YoY growth
+79.1%
Most recent quarter
EPS YoY growth
-10.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+13.8%
2026-03-17
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-17 | $-0.22 | +36.7% | $3.56 | $4.05 | +13.8% |
| 2025-11-05 | $-0.69 | -452.0% | $3.97 | $3.51 | -11.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.35 | $-0.22 | +36.7% | $2.57M | +79.1% |
| 2025-09-30 | $-0.13 | $-0.69 | -452.0% | $1.76M | +215.2% |
| 2025-06-30 | $-0.09 | $-3.47 | -3829.8% | $1.97M | +250.4% |
| 2025-03-31 | $-3.75 | $0.04 | +101.1% | $28.81M | — |
| 2024-12-31 | $-0.16 | $-0.20 | -27.0% | $1.43M | -53.1% |
| 2024-09-30 | $-0.17 | $-0.18 | -5.9% | $560000.00 | — |
| 2024-06-30 | $0.01 | $-0.07 | -800.0% | $563000.00 | — |
| 2024-03-31 | $-0.16 | $-0.26 | -62.5% | — | — |
| 2023-12-31 | $-0.15 | $-0.10 | +33.3% | $3.06M | — |
| 2023-09-30 | $-0.15 | $-0.01 | +93.3% | — | — |
| 2023-06-30 | $-0.16 | $-0.33 | -106.3% | — | — |
| 2023-03-31 | $-0.22 | $-0.16 | +27.3% | — | — |
Frequently asked questions
Has X4 Pharmaceuticals Inc beaten earnings estimates?
X4 Pharmaceuticals Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -65.6% over the last 4 quarters.
How does XFOR stock react to earnings?
XFOR stock has moved an average of +1.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is X4 Pharmaceuticals Inc's revenue growth rate?
X4 Pharmaceuticals Inc reported year-over-year revenue growth of +79.1% in its most recent quarter, with EPS growing -10.0% year-over-year.